BTAI

BioXcel Therapeutics (BTAI) is the lead sponsor of 1 active clinical trials listed on ClinicalTrials.gov^[2], including 1 Phase 1^[1].

BTAI has 4 Form 4 insider filings recorded at the SEC in the past 30 days^[3].